¼¼°èÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀå
Digital Health for Obesity
»óǰÄÚµå : 1786433
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 281 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,204,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,612,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀåÀº 2030³â±îÁö 1,687¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 565¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 20.0%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 1,687¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ¼ÒÇÁÆ®¿þ¾î ÄÄÆ÷³ÍÆ®´Â CAGR 17.7%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 874¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Çϵå¿þ¾î ÄÄÆ÷³ÍÆ® ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 23.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 154¾ï ´Þ·¯, Áß±¹Àº CAGR 26.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ºñ¸¸¿ë µðÁöÅÐ Çコ ½ÃÀåÀº 2024³â¿¡ 154¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 390¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 26.6%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 16.2%¿Í 17.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 16.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ºñ¸¸ µðÁöÅÐ Çコ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

AI¸¦ Ȱ¿ëÇÑ °Ç°­ ¾ÛÀÌ Àü ¼¼°è ºñ¸¸ ¹®Á¦¸¦ ÇØ°áÇÒ ¼ö Àִ°¡?

¼¼°è ºñ¸¸ À§±â´Â °³ÀÎÈ­µÈ üÁß °ü¸® ÇÁ·Î±×·¥À» Á¦°øÇÏ´Â AI ±â¹Ý µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ ºü¸¥ µµÀÔÀ» ÅëÇØ ÇØ°áµÇ°í ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ Ã¼Áß °¨·® Á¢±Ù¹ýÀº °³º°È­, Ã¥ÀÓ°¨, Àå±âÀûÀÎ Çൿ Áö¿øÀÇ ºÎÁ·À¸·Î ÀÎÇØ Á¾Á¾ ½ÇÆÐÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. µðÁöÅÐ °Ç°­ ¿ëµµ´Â ÇöÀç AI ±â¹Ý ½Ä»ç °èȹ, ½ÅÁø´ë»ç ÃßÀû, Çൿ ÄÚĪÀ» ÅëÇÕÇÏ¿© °³ÀÎÀÇ Çʿ信 ¸Â´Â ÀûÀÀÇü üÁß °¨·® ÇÁ·Î±×·¥À» ¸¸µé°í ÀÖ½À´Ï´Ù. AI ¾Ë°í¸®ÁòÀº »ç¿ëÀÚÀÇ ½Ä½À°ü, ½Åü Ȱµ¿ ¼öÁØ, ´ë»ç ¹ÝÀÀÀ» ºÐ¼®ÇÏ¿© ¸ÂÃãÇü ¿µ¾ç ¹× ÇÇÆ®´Ï½º ÃßõÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ´®(Noom)À̳ª ¶óÅ©(Lark)¿Í °°Àº µðÁöÅÐ ÄÚĪ Ç÷§ÆûÀº AI ±â¹Ý 꺿À» ÅëÇØ ½Ç½Ã°£ µ¿±âºÎ¿©¿Í ¼øÀÀÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº Á¢±Ù¼º°ú °³ÀÎÈ­¸¦ Çâ»ó½ÃŰÁö¸¸, AI ±â¹Ý ÃßõÀÇ Á¤È®¼º°ú µðÁöÅРüÁß °ü¸® Àü·«ÀÇ Àå±âÀû Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ ¿ì·Á´Â ¿©ÀüÈ÷ ³²¾ÆÀÖ½À´Ï´Ù. ÇÏÁö¸¸ AI ±â¹Ý °Ç°­ ÄÚĪÀÌ °è¼Ó ¹ßÀüÇÔ¿¡ µû¶ó ºñ¸¸ ÅðÄ¡, ÀÇ·á ºñ¿ë Àý°¨, °øÁß º¸°Ç °á°ú °³¼±¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

¿ø°Ý ¸ð´ÏÅ͸µÀº ¾î¶»°Ô üÁß °ü¸®¸¦ °­È­Çϴ°¡?

ºñ¸¸ °ü¸®¿¡¼­ ¿ø°Ý ¸ð´ÏÅ͸µ ÅøÀÇ ÅëÇÕÀº üÁß º¯È­, Ä®·Î¸® ¼·Ãë·®, ½Åü Ȱµ¿ ¼öÁذú °°Àº Áß¿äÇÑ °Ç°­ ÁöÇ¥¸¦ Áö¼ÓÀûÀ¸·Î ÃßÀûÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á ȯÀÚÀÇ °á°ú¸¦ Å©°Ô °³¼±Çϰí ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ǷΠ¿¬°áµÈ ¿þ¾î·¯ºí ÇÇÆ®´Ï½º Æ®·¡Ä¿¿Í ½º¸¶Æ® üÁ߰踦 ÅëÇØ »ç¿ëÀÚ´Â ÀÚ½ÅÀÇ ÁøÇà »óȲÀ» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖÀ¸¸ç, üÁß °¨·® ÇÁ·Î±×·¥ Áؼö¸¦ ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. Áö¼ÓÀû Æ÷µµ´ç ¸ð´ÏÅ͸µ(CGM) ±â¼ú ¶ÇÇÑ ´Ù¾çÇÑ ½ÄǰÀÌ Ç÷´ç°ú ´ë»ç ¹ÝÀÀ¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÔÀ¸·Î½á °³ÀÎ ¸ÂÃãÇü ºñ¸¸ °ü¸®ÀÇ Áß¿äÇÑ ¿ä¼Ò·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á ¼­ºñ½º´Â ¿µ¾ç»ç, ³»ºÐºñ³»°ú Àü¹®ÀÇ, Çൿġ·á»ç¿Í ȯÀÚ¸¦ ¿ø°ÝÀ¸·Î ¿¬°áÇØ ºñ¸¸ Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ´õ¿í Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ±×·¯³ª ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀº ±ÍÁßÇÑ µ¥ÀÌÅͺ£À̽º ÀλçÀÌÆ®¸¦ Á¦°øÇÏÁö¸¸, »ç¿ëÀÚ Âü¿© À¯Áö, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã, Àåºñ °¡°Ý µîÀÇ ¹®Á¦¸¦ ÇØ°áÇØ¾ß ÇÏ´Â °úÁ¦¸¦ ¿©ÀüÈ÷ ¾È°í ÀÖ½À´Ï´Ù. ±â¼úÀÌ ¹ßÀüÇÏ°í ¿ø°Ý °Ç°­ ¸ð´ÏÅ͸µÀÌ ´õ¿í ¿øÈ°ÇØÁü¿¡ µû¶ó ºñ¸¸ °ü¸®¸¦ À§ÇÑ µðÁöÅÐ ¼Ö·ç¼ÇÀº Á¡Á¡ ´õ È¿°úÀûÀÌ µÇ¾î º¸´Ù Áö¼Ó°¡´ÉÇÑ Ã¼Áß °¨·® ¼º°ú¸¦ ´Þ¼ºÇÒ ¼ö ÀÖ´Â ±æÀ» ¿­¾îÁÙ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

µðÁöÅÐ Ä¡·á(DTx)´Â ºñ¸¸ Ä¡·áÀÇ ¹Ì·¡Àΰ¡?

µðÁöÅÐ Ä¡·á(DTx)´Â üÁß Áõ°¡ÀÇ ¿øÀÎÀÌ µÇ´Â ÇൿÀû, ½É¸®Àû, »ý¸®Àû ¿äÀÎÀ» ÇØ°áÇÔÀ¸·Î½á Áõ°Å¿¡ ±â¹ÝÇÑ ºñ¸¸ Ä¡·á Á¢±Ù¹ýÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ ´ÙÀÌ¾îÆ® ¾Û°ú ´Þ¸® DTx ¼Ö·ç¼ÇÀº ÀÓ»óÀûÀ¸·Î °ËÁõµÇ°í üÁß °¨·®À» À§ÇÑ ±¸Á¶È­µÈ °³ÀÔÀ» Á¦°øÇϵµ·Ï ¼³°èµÇ¾úÀ¸¸ç, ÀÎÁöÇൿġ·á(CBT) ¹× ½À°ü ÃßÀû ¾Ë°í¸®Áò°ú °°Àº Çൿ ±³Á¤ ±â¼úÀ» ÅëÇÕÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. Virta Health¿Í °°Àº AI ±â¹Ý ´ë»ç °Ç°­ Ç÷§ÆûÀº Áö¼ÓÀûÀΠȯÀÚ µ¥ÀÌÅ͸¦ Ȱ¿ëÇÏ¿© ½Ä´Ü ÁßÀ縦 ÃÖÀûÈ­Çϰí Àå±âÀûÀΠüÁß °¨·® ¼º°ø·üÀ» Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ °¡»ó ÄÚĪ ÇÁ·Î±×·¥ ¹× ¸ð¹ÙÀÏ ±â¹Ý ÁßÀç°¡ üÁß °¨·® ¾à¹°°ú ÅëÇÕµÇ¾î º¹¾à ¼øÀÀµµ¸¦ ³ôÀ̰í È¿´ÉÀ» °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ºñ¸¸ °ü¸®¿¡¼­ DTxÀÇ ÀáÀç·Â¿¡µµ ºÒ±¸ÇÏ°í ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, »óȯ Á¤Ã¥, Àå±âÀû À¯È¿¼º ¿¬±¸ µîÀÌ ¿©ÀüÈ÷ Áß¿äÇÑ Àå¾Ö¹°ÀÔ´Ï´Ù. ±×·¯³ª µðÁöÅÐ ºñ¸¸ Ä¡·áÀÇ È¿°ú¸¦ Áö¿øÇÏ´Â ÀÓ»óÀû ±Ù°Å°¡ ´Ã¾î³²¿¡ µû¶ó äÅÃÀÌ È®´ëµÇ°í ºñ¸¸ Ä¡·áÀÇ ÆÐ·¯´ÙÀÓÀÌ ¹Ù²ð °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºñ¸¸ µðÁöÅÐ Çコ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº?

ºñ¸¸ µðÁöÅÐ Çコ ½ÃÀåÀÇ ¼ºÀåÀº ºñ¸¸ À¯º´·ü Áõ°¡, ÀÇ·áºñ »ó½Â, AI¸¦ Ȱ¿ëÇÑ Ã¼Áß °ü¸® ¼Ö·ç¼ÇÀÇ ¹ßÀü µî ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí °Ç°­ ±â±â ¹× ¸ð¹ÙÀÏ °Ç°­ ¿ëµµÀÇ Ã¤ÅÃÀ¸·Î °³ÀÎÈ­µÈ üÁß °ü¸®°¡ ´õ¿í Ä£¼÷Çϰí È®Àå °¡´ÉÇÑ ÇüÅ·Πº¯È­Çϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á ¼­ºñ½º ¹× °¡»ó ÄÚĪ ÇÁ·Î±×·¥ÀÇ È®´ë·Î ȯÀÚ Âü¿©µµ°¡ Çâ»óµÇ°í ´ë¸é Áø·áÀÇ Çʿ伺ÀÌ °¨¼ÒÇϰí ÀÖ½À´Ï´Ù. AI, Çൿ°úÇÐ, µ¥ÀÌÅÍ ºÐ¼®ÀÇ ÅëÇÕÀº º¸´Ù È¿°úÀûÀÌ°í °³ÀÎÈ­µÈ üÁß °¨·® ÁßÀ縦 °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. µðÁöÅÐ Ä¡·áÁ¦¿¡ ´ëÇÑ ±ÔÁ¦ Áö¿ø°ú µðÁöÅРüÁß °ü¸® ÇÁ·Î±×·¥¿¡ ´ëÇÑ º¸Çè Àû¿ë Áõ°¡´Â ½ÃÀå µµÀÔÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´ë»ç °Ç°­¿¡ ƯȭµÈ µðÁöÅÐ Çコ ½ºÅ¸Æ®¾÷¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϸ鼭 ºñ¸¸ °ü¸®ÀÇ Çõ½ÅÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. Àü ¼¼°è¿¡¼­ ºñ¸¸À²ÀÌ °è¼Ó Áõ°¡Çϰí ÀÖ´Â °¡¿îµ¥, µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀº Áö¼Ó°¡´ÉÇÑ Ã¼Áß °ü¸®¸¦ À§ÇØ ºñ¿ë È¿À²ÀûÀ̰í È®Àå °¡´ÉÇϸç Áõ°Å¿¡ ±â¹ÝÇÑ °³ÀÔÀ» Á¦°øÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

ºÎ¹®

ÄÄÆ÷³ÍÆ®(¼ÒÇÁÆ®¿þ¾î ÄÄÆ÷³ÍÆ®, Çϵå¿þ¾î ÄÄÆ÷³ÍÆ®, ¼­ºñ½º); ÃÖÁ¾»ç¿ëÀÚ(ȯÀÚ ÃÖÁ¾»ç¿ëÀÚ, ÀÇ·á Á¦°øÀÚ ÃÖÁ¾»ç¿ëÀÚ, ÁöºÒÀÚ ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Digital Health for Obesity Market to Reach US$168.7 Billion by 2030

The global market for Digital Health for Obesity estimated at US$56.5 Billion in the year 2024, is expected to reach US$168.7 Billion by 2030, growing at a CAGR of 20.0% over the analysis period 2024-2030. Software Component, one of the segments analyzed in the report, is expected to record a 17.7% CAGR and reach US$87.4 Billion by the end of the analysis period. Growth in the Hardware Component segment is estimated at 23.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$15.4 Billion While China is Forecast to Grow at 26.6% CAGR

The Digital Health for Obesity market in the U.S. is estimated at US$15.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$39.0 Billion by the year 2030 trailing a CAGR of 26.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.2% and 17.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.7% CAGR.

Global Digital Health for Obesity Market - Key Trends & Drivers Summarized

Can AI-Powered Health Apps Tackle the Global Obesity Epidemic?

The global obesity crisis is being addressed through the rapid adoption of AI-powered digital health solutions that offer personalized weight management programs. Traditional weight loss approaches often fail due to a lack of personalization, accountability, and long-term behavioral support. Digital health applications are now integrating AI-driven meal planning, metabolic tracking, and behavioral coaching to create adaptive weight loss programs tailored to individual needs. AI algorithms analyze users’ dietary habits, physical activity levels, and metabolic responses to provide customized nutrition and fitness recommendations. Additionally, digital coaching platforms such as Noom and Lark use AI-powered chatbots to provide real-time motivation and adherence support. While these solutions enhance accessibility and personalization, concerns regarding the accuracy of AI-driven recommendations and the long-term sustainability of digital weight management strategies remain. Nevertheless, as AI-driven health coaching continues to advance, it is expected to play a critical role in combating obesity, reducing healthcare costs, and improving public health outcomes.

How Is Remote Monitoring Enhancing Weight Management?

The integration of remote monitoring tools in obesity management is significantly improving patient outcomes by enabling continuous tracking of vital health metrics such as weight fluctuations, calorie intake, and physical activity levels. Wearable fitness trackers and smart scales connected to mobile applications allow users to monitor their progress in real-time, promoting adherence to weight loss programs. Continuous glucose monitoring (CGM) technology is also emerging as a key component of personalized obesity management, providing insights into how different foods affect blood sugar levels and metabolic responses. Telehealth services are further enhancing access to obesity care by connecting patients with nutritionists, endocrinologists, and behavioral therapists remotely. However, while remote monitoring solutions provide valuable data-driven insights, challenges such as user engagement retention, data privacy, and device affordability still need to be addressed. As technology improves and remote health monitoring becomes more seamless, digital solutions for obesity management are expected to become increasingly effective, paving the way for more sustainable weight loss outcomes.

Are Digital Therapeutics (DTx) the Future of Obesity Treatment?

Digital therapeutics (DTx) are emerging as an evidence-based approach to treating obesity by addressing behavioral, psychological, and physiological factors contributing to weight gain. Unlike traditional diet apps, DTx solutions are clinically validated and designed to provide structured interventions for weight loss, often incorporating behavioral modification techniques such as cognitive behavioral therapy (CBT) and habit-tracking algorithms. AI-powered metabolic health platforms, such as Virta Health, use continuous patient data to optimize dietary interventions, improving long-term weight loss success rates. Additionally, virtual coaching programs and mobile-based interventions are being integrated with weight-loss medications to enhance adherence and improve efficacy. Despite the potential of DTx in obesity management, regulatory approvals, reimbursement policies, and long-term efficacy studies remain key hurdles. However, as more clinical evidence supports the effectiveness of digital obesity treatments, adoption is expected to grow, leading to a paradigm shift in obesity care.

What Is Driving the Growth of the Digital Health for Obesity Market?

The growth in the digital health for obesity market is driven by several key factors, including increasing obesity prevalence, rising healthcare costs, and advancements in AI-driven weight management solutions. The adoption of wearable health devices and mobile health applications is making personalized weight management more accessible and scalable. The expansion of telehealth services and virtual coaching programs is improving patient engagement, reducing the need for in-person consultations. The integration of AI, behavioral science, and data analytics is enabling more effective, individualized weight-loss interventions. Regulatory support for digital therapeutics and increasing insurance coverage for digital weight management programs are further driving market adoption. Additionally, growing investment in digital health startups specializing in metabolic health is accelerating innovation in obesity care. As obesity rates continue to rise globally, digital health solutions are expected to play a crucial role in providing cost-effective, scalable, and evidence-based interventions for sustainable weight management.

SCOPE OF STUDY:

The report analyzes the Digital Health for Obesity market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software Component, Hardware Component, Services); End-Use (Patients End-Use, Providers End-Use, Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â